Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Deficits
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2019 $ 9,392 $ 69,560,529 $ (23,271,687) $ (482,639) $ 45,815,595
Balance, Shares at Dec. 31, 2019 9,391,729        
Stock compensation expense   464,827     464,827
Revaluation of stock warrant   (66,200)     (66,200)
Other comprehensive income       343,775 343,775
Net loss for the period     (2,366,494)   (2,366,494)
Balance (Unaudited), at Mar. 31, 2020 $ 9,392 69,959,156 (25,638,181) (138,864) 44,191,503
Balance (Unaudited), Shares at Mar. 31, 2020 9,391,729        
Balance at Dec. 31, 2020 $ 9,488 73,160,616 (32,383,833) (1,754,228) 39,032,043
Balance, Shares at Dec. 31, 2020 9,487,889        
Stock compensation expense 1,680,365 1,680,365
Revaluation of stock warrant (355,600) (355,600)
Other comprehensive income 393,767 393,767
Net loss for the period (4,228,126) (4,228,126)
Balance (Unaudited), at Mar. 31, 2021 $ 9,488 $ 74,485,381 $ (36,611,959) $ (1,360,461) $ 36,522,449
Balance (Unaudited), Shares at Mar. 31, 2021 9,487,889